Literature DB >> 26295564

Finnish guidelines for the treatment of laryngitis, wheezing bronchitis and bronchiolitis in children.

Terhi Tapiainen1,2, Janne Aittoniemi3, Johanna Immonen4, Heli Jylkkä5, Tuula Meinander6, Kirsi Nuolivirta7, Ville Peltola8, Eeva Salo9, Raija Seuri10, Satu-Maaria Walle11, Matti Korppi12.   

Abstract

UNLABELLED: Evidence-based guidelines are needed to harmonise and improve the diagnostics and treatment of children's lower respiratory tract infections. Following a professional literature search, an interdisciplinary working group evaluated and graded the available evidence and constructed guidelines for treating laryngitis, bronchitis, wheezing bronchitis and bronchiolitis.
CONCLUSION: Currently available drugs were not effective in relieving cough symptoms. Salbutamol inhalations could relieve the symptoms of wheezing bronchitis and should be administered via a holding chamber. Nebulised adrenaline or inhaled or oral glucocorticoids did not reduce hospitalisation rates or relieve symptoms in infants with bronchiolitis and should not be routinely used. ©2015 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Bronchiolitis; Bronchitis; Cough; Laryngitis; Wheezing bronchitis

Mesh:

Substances:

Year:  2015        PMID: 26295564     DOI: 10.1111/apa.13162

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  9 in total

1.  Re: "Discharge Criteria for Bronchiolitis: Does Age Matter?"

Authors:  Cristina Garcia-Mauriño; Melissa Moore-Clingenpeel; Octavio Ramilo; Asuncion Mejias
Journal:  Pediatr Infect Dis J       Date:  2018-12       Impact factor: 2.129

2.  Discharge Criteria for Bronchiolitis: An Unmet Need.

Authors:  Cristina Garcia-Mauriño; Melissa Moore-Clingenpeel; Rebecca Wallihan; Katalin Koranyi; Bavani Rajah; Tiffany Shirk; Maria Vegh; Octavio Ramilo; Asuncion Mejias
Journal:  Pediatr Infect Dis J       Date:  2018-06       Impact factor: 2.129

3.  Effect of Point-of-Care Testing for Respiratory Pathogens on Antibiotic Use in Children: A Randomized Clinical Trial.

Authors:  Suvi Mattila; Niko Paalanne; Minna Honkila; Tytti Pokka; Terhi Tapiainen
Journal:  JAMA Netw Open       Date:  2022-06-01

4.  Antibiotic prescribing for children with upper respiratory tract infection: a Finnish nationwide 7-year observational study.

Authors:  Matti Korppi; Paula Heikkilä; Sauli Palmu; Heini Huhtala; Péter Csonka
Journal:  Eur J Pediatr       Date:  2022-05-23       Impact factor: 3.860

5.  The change in management of bronchiolitis in the intensive care unit between 2000 and 2015.

Authors:  Minna Mecklin; Paula Heikkilä; Matti Korppi
Journal:  Eur J Pediatr       Date:  2018-05-15       Impact factor: 3.183

6.  Marked variability observed in inpatient management of bronchiolitis in three Finnish hospitals.

Authors:  Varpu Elenius; Eija Bergroth; Petri Koponen; Sami Remes; Pedro A Piedra; Janice A Espinola; Matti Korppi; Carlos A Camargo; Tuomas Jartti
Journal:  Acta Paediatr       Date:  2017-06-16       Impact factor: 2.299

Review 7.  Immunity-targeted approaches to the management of chronic and recurrent upper respiratory tract disorders in children.

Authors:  Wojciech Feleszko; Ricardo Marengo; Antonio Sousa Vieira; Karol Ratajczak; José Luis Mayorga Butrón
Journal:  Clin Otolaryngol       Date:  2019-04-14       Impact factor: 2.597

8.  [Criteria heterogeneity in the diagnosis of acute bronchiolitis in Spain].

Authors:  Alfredo Cano-Garcinuño; Manuel Praena-Crespo; Isabel Mora-Gandarillas; Ignacio Carvajal-Urueña; María Teresa Callén-Blecua; Águeda García-Merino
Journal:  An Pediatr (Engl Ed)       Date:  2018-08-29

9.  Criteria heterogeneity in the diagnosis of acute bronchiolitis in Spain.

Authors:  Alfredo Cano-Garcinuño; Manuel Praena-Crespo; Isabel Mora-Gandarillas; Ignacio Carvajal-Urueña; María Teresa Callén-Blecua; Águeda García-Merino
Journal:  An Pediatr (Engl Ed)       Date:  2018-12-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.